To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene JARID2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
351 supporting clones for gene JARID2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA019040   .a 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
2 diff
(99.7 %id)
DA439019 tongue, tumor tissue .a 18 to 602 2 to 586   capped   585/586
(99 %)
1 diff
(99.9 %id)
DA459041 tongue, tumor tissue .a 18 to 585 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA068312 cerebellum .a 37 to 602 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
CN266539 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 37 to 436 1 to 401       401/401
(100 %)
3 diff
(99.3 %id)
BM152662 leukopheresis .a 61 to 232 1 to 173       173/175
(98 %)
7 diff
(96.0 %id)
DA461007 tongue, tumor tissue .a 63 to 599 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA858487 placenta .a 63 to 630 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB222812 trachea .a 63 to 610 2 to 551   capped   550/588
(93 %)
5 diff
(99.2 %id)
DA095742 cerebellum .a 65 to 603 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA460172 tongue, tumor tissue .a 65 to 609 2 to 547   capped   546/548
(99 %)
2 diff
(99.7 %id)
DA722392   .a 65 to 610 2 to 548   capped   547/569
(96 %)
4 diff
(99.3 %id)
DA864913 placenta .a 65 to 610 2 to 548   capped   547/552
(99 %)
2 diff
(99.7 %id)
AL712058 human skeletal muscle .a 87 to 610 1 to 524       524/612
(85 %)
2 diff
(99.7 %id)
DW457112 Liver .a 94 to 240 18 to 164       147/164
(89 %)
6 diff
(96.4 %id)
AW892327 nervous_normal .a 95 to 513 425 to 3       423/426
(99 %)
0 diff
(100 %id)
DA071874 cerebellum .a 96 to 667 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA765316 tongue .a 96 to 610 2 to 517   capped   516/576
(89 %)
5 diff
(99.2 %id)
DA435804 tongue, tumor tissue .a 97 to 587 2 to 494   capped   493/493
(100 %)
5 diff
(99.0 %id)
DA811475 brain .a 97 to 610 2 to 515   capped   514/561
(91 %)
4 diff
(99.3 %id)
DB282756 uterus .a 97 to 610 2 to 517   capped   516/548
(94 %)
4 diff
(99.3 %id)
DN993621 brain, whole brain .a 107 to 831 1 to 724       724/724
(100 %)
6 diff
(99.2 %id)
BG574656.
matches multiple genes
breast, Breast, mammary adenocarcinoma., mammary adenocarcinoma, cell line .a 135 to 1024 1 to 896   available from MGC, also hits gene RIPPLY2andCYB5R4 896/897
(99 %)
21 diff
(97.7 %id)
AK292861 trachea .a 154 to 4488 1 to 4335 exact tiling clone,   4335/4335
(100 %)
1 diff
(100.0 %id)
DB220725 trachea .a 155 to 724 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BC046246 Testis, embryonal carcinoma .a 283 to 5125 1 to 4843 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 4843/4843
(100 %)
0 diff
(100 %id)
BG387656 embryonal carcinoma, cell line, testis .a 284 to 972 1 to 690       690/690
(100 %)
8 diff
(98.9 %id)
NM_004973.2   .a 321 to 6076 1 to 5756 exact RefSeq,   5756/5756
(100 %)
0 diff
(100 %id)
U57592   .a 321 to 4384 1 to 4067 D673E A681S R688K D692E L705I ...     4067/4068
(99 %)
20 diff
(99.6 %id)
DC300228   .a 604 to 1092 93 to 582       490/582
(84 %)
7 diff
(98.8 %id)
AK303610 thymus .a 607 to 4420 51 to 3864       3814/3864
(98 %)
7 diff
(99.9 %id)
DC410567 thymus .a 607 to 1154 51 to 599       549/599
(91 %)
6 diff
(99.0 %id)
DB230278 trachea .a 607 to 1058 98 to 550   capped   453/549
(82 %)
6 diff
(99.0 %id)
BE903770 choriocarcinoma, placenta .a 609 to 1261 63 to 716       654/716
(91 %)
17 diff
(97.7 %id)
BF852754 lung_normal .a 610 to 850 162 to 402       241/402
(59 %)
6 diff
(98.6 %id)
DB288286 uterus .a 610 to 1008 118 to 516   capped   399/515
(77 %)
6 diff
(98.9 %id)
CD619527   .a 832 to 1432 12 to 611       600/635
(94 %)
12 diff
(98.2 %id)
CD619532   .a 832 to 1426 12 to 600       589/602
(97 %)
13 diff
(97.9 %id)
CD619533   .a 832 to 1607 12 to 787       776/794
(97 %)
13 diff
(98.4 %id)
CD619535   .a 832 to 1616 10 to 796       787/796
(98 %)
19 diff
(97.7 %id)
CD619537   .a 832 to 1426 11 to 604       594/606
(98 %)
11 diff
(98.2 %id)
CD619538   .a 832 to 1432 610 to 9       602/622
(96 %)
2 diff
(99.7 %id)
AA223818 brain, neuroepithelial cells .a 833 to 1230 1 to 399       399/399
(100 %)
3 diff
(99.3 %id)
BQ433506 embryonal carcinoma, cell line, testis .a 835 to 1540 221 to 928       708/928
(76 %)
17 diff
(98.2 %id)
CD619529   .a 836 to 1426 14 to 599       586/601
(97 %)
12 diff
(98.1 %id)
CD619530   .a 836 to 1426 590 to 3       588/604
(97 %)
3 diff
(99.6 %id)
CD619528   .a 845 to 1426 583 to 2       582/583
(99 %)
0 diff
(100 %id)
CD619531   .a 845 to 1426 578 to 2       577/578
(99 %)
2 diff
(99.7 %id)
CD619536   .a 900 to 1631 736 to 3       734/736
(99 %)
10 diff
(98.7 %id)
CR978397 T-Lymphocytes .a 919 to 1803 1 to 886       886/886
(100 %)
13 diff
(98.6 %id)
DB068639 testis .a 946 to 1490 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA460837 tongue, tumor tissue .a 970 to 1527 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BM151662 leukopheresis .a 981 to 1498 1 to 518       518/518
(100 %)
0 diff
(100 %id)
DB144172 thymus .a 1012 to 1555 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BE618437 eye, retinoblastoma .a 1061 to 1587 1 to 519       519/519
(100 %)
22 diff
(95.8 %id)
DB131836 thymus .a 1142 to 1698 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA498006 brain .a 1148 to 1731 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CD619534   .a 1149 to 1607 462 to 3       460/462
(99 %)
1 diff
(99.8 %id)
DA105838 cerebellum .a 1166 to 1713 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BI256289 cervical carcinoma cell line, cervix .a 1182 to 1996 1 to 838       838/865
(96 %)
55 diff
(93.7 %id)
CD652986 Embryonic Stem cells .a 1194 to 1960 1 to 767       767/768
(99 %)
9 diff
(98.9 %id)
BP366369   .a 1212 to 1795 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA124724 cerebellum .a 1262 to 1787 2 to 529   capped   528/528
(100 %)
3 diff
(99.5 %id)
BP217701 caudate nucleus .a 1317 to 1897 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CD643665 Embryonic Stem cells .a 1442 to 2226 8 to 789       782/820
(95 %)
19 diff
(97.7 %id)
AL041595 testis .a 1489 to 1823 1 to 335       335/335
(100 %)
0 diff
(100 %id)
DA809842 brain .a 1534 to 2131 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
BM829064 Ascites, stomach .a 1636 to 1836 1 to 201       201/201
(100 %)
0 diff
(100 %id)
CN288385 embryonic stem cells, cell lines H1, H7, andH9 .a 1666 to 2138 1 to 473       473/473
(100 %)
2 diff
(99.6 %id)
DA544071   .a 1718 to 2251 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
CN288384 embryonic stem cells, DMSO-treated H9 cellline .a 1730 to 2298 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DA043631 bladder .a 1787 to 2354 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CN288381 embryonic stem cells, cell lines H1, H7, andH9 .a 1948 to 2699 1 to 752       752/752
(100 %)
1 diff
(99.9 %id)
BF206138 brain, neuroblastoma .a 2081 to 2748 1 to 667       667/992
(67 %)
7 diff
(99.3 %id)
BF311359 brain, neuroblastoma .a 2081 to 2739 1 to 659       659/1100
(59 %)
2 diff
(99.9 %id)
BF311414 brain, neuroblastoma .a 2081 to 2744 1 to 664       664/668
(99 %)
5 diff
(99.3 %id)
BG773583 choriocarcinoma, placenta .a 2261 to 2966 1 to 703       703/703
(100 %)
13 diff
(98.2 %id)
CX752892 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2434 to 3091 1 to 653     Submitted on the opposite strand 653/834
(78 %)
56 diff
(93.3 %id)
DA292305 hippocampus .a 2551 to 3141 2 to 593   capped   592/592
(100 %)
3 diff
(99.5 %id)
DB069387 testis .a 2590 to 3127 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
CN288378 embryonic stem cells, cell lines H1, H7, andH9 .a 2598 to 2938 1 to 341       341/341
(100 %)
0 diff
(100 %id)
CN288387 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2602 to 2946 1 to 345       345/345
(100 %)
0 diff
(100 %id)
DA387590 thalamus .a 2627 to 3214 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
CN288383 embryonic stem cells, DMSO-treated H9 cellline .a 2642 to 3188 1 to 547       547/547
(100 %)
0 diff
(100 %id)
CX756991 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2681 to 3410 1 to 725     Submitted on the opposite strand 725/861
(84 %)
9 diff
(99.0 %id)
CX751579 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2714 to 3369 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BU595639 mixed (pool of 40 RNAs) .a 2862 to 3524 1 to 663       663/752
(88 %)
7 diff
(99.1 %id)
DA103973 cerebellum .a 2865 to 3420 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
BM145921 leukopheresis .a 2903 to 3349 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AL709853 human skeletal muscle .a 2938 to 3642 1 to 705       705/705
(100 %)
4 diff
(99.5 %id)
BX643565   .a 2940 to 3484 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
BI551742 brain, hippocampus .a 3013 to 3484 349 to 816       468/817
(57 %)
13 diff
(98.5 %id)
BM145855 leukopheresis .a 3015 to 3349 335 to 1       335/342
(97 %)
5 diff
(98.6 %id)
CN288379 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3020 to 3629 9 to 619       611/619
(98 %)
1 diff
(99.9 %id)
AU125882   .a 3030 to 3793 2 to 765   capped   764/764
(100 %)
6 diff
(99.3 %id)
CD676149 eye, lens .a 3065 to 3685 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BU178035 melanotic melanoma, skin .a 3170 to 4017 1 to 863       863/875
(98 %)
24 diff
(97.3 %id)
BX279637 breast, mammary adenocarcinoma, cell line .a 3195 to 3650 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BI857543 breast, mammary adenocarcinoma, cell line .a 3195 to 3947 1 to 756       756/758
(99 %)
8 diff
(99.0 %id)
BC046184 Breast, mammary adenocarcinoma. .a 3195 to 5125 1 to 1932   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1932/1932
(100 %)
4 diff
(99.8 %id)
TI_57187336   .a 3195 to 3947 49 to 804       756/758
(99 %)
8 diff
(99.0 %id)
TI_57187601   .a 3196 to 3937 50 to 827       757/778
(97 %)
57 diff
(92.7 %id)
BI857297 breast, mammary adenocarcinoma, cell line .a 3197 to 3937 1 to 777   available from MGC,   756/777
(97 %)
57 diff
(92.7 %id)
BU187019 eye, retinoblastoma .a 3198 to 4072 1 to 877       877/884
(99 %)
5 diff
(99.5 %id)
AU134524 ovary, tumor tissue .a 3203 to 3969 2 to 767   capped   766/766
(100 %)
5 diff
(99.4 %id)
BG981191 colon_normal .a 3234 to 3654 5 to 423       419/423
(99 %)
8 diff
(98.2 %id)
BF741472 bocio_tumor .a 3247 to 3604 23 to 376       354/376
(94 %)
6 diff
(98.5 %id)
BG981124 colon_normal .a 3247 to 3457 1 to 211       211/211
(100 %)
0 diff
(100 %id)
DA672546   .a 3382 to 3973 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BE938430 testis_normal .a 3408 to 3600 1 to 190       190/190
(100 %)
7 diff
(96.4 %id)
BM542826 embryonal carcinoma, cell line, testis .a 3455 to 4122 1 to 669       669/1040
(64 %)
4 diff
(99.7 %id)
BI046151 prostate_normal .a 3501 to 4044 3 to 547       545/564
(96 %)
26 diff
(95.4 %id)
BF852202 lung_normal .a 3520 to 4033 25 to 537       513/537
(95 %)
12 diff
(97.8 %id)
AW573001 pooled .a 3535 to 3778 244 to 1       244/244
(100 %)
3 diff
(98.8 %id)
BF109026 pooled .a 3540 to 3772 233 to 1       233/233
(100 %)
0 diff
(100 %id)
BF315231 brain, neuroblastoma .a 3553 to 4303 740 to 2     Submitted on the opposite strand 739/924
(79 %)
19 diff
(98.0 %id)
BE548611 cervical carcinoma cell line, cervix .a 3568 to 4072 1 to 527       527/527
(100 %)
41 diff
(92.3 %id)
AA074295 pineal gland .a 3606 to 3768 1 to 164       164/166
(98 %)
2 diff
(98.8 %id)
CR980238 T-Lymphocytes .a 3607 to 4358 1 to 752       752/752
(100 %)
3 diff
(99.7 %id)
BG674150 skin .a 3610 to 4392 1 to 789       789/970
(81 %)
28 diff
(97.2 %id)
AF401209   .a 3637 to 3777 1 to 141       141/141
(100 %)
0 diff
(100 %id)
BM470803 eye, retinoblastoma .a 3692 to 4639 13 to 971       959/1038
(92 %)
20 diff
(98.1 %id)
TI_57186961   .a 3694 to 4489 58 to 857       800/800
(100 %)
20 diff
(97.5 %id)
BI858333 breast, mammary adenocarcinoma, cell line .a 3695 to 4489 1 to 799       799/799
(100 %)
20 diff
(97.5 %id)
BF206375 brain, neuroblastoma .a 3697 to 4303 600 to 2     Submitted on the opposite strand 599/918
(65 %)
12 diff
(98.7 %id)
BE313370 brain, neuroblastoma .a 3754 to 4284 532 to 1     Submitted on the opposite strand 532/532
(100 %)
2 diff
(99.7 %id)
CN288386 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3801 to 4392 1 to 592       592/592
(100 %)
6 diff
(99.0 %id)
BP421546 small intestine .a 3818 to 4345 1 to 528     Submitted on the opposite strand 528/528
(100 %)
1 diff
(99.9 %id)
BE732886 choriocarcinoma, placenta .a 3849 to 4596 1 to 741       741/875
(84 %)
16 diff
(98.2 %id)
CR590032 HeLa cells Cot 25-normalized .a 3860 to 5155 1 to 1296   tiling clone,   1296/1296
(100 %)
0 diff
(100 %id)
AL555850 placenta .a 3860 to 4810 1 to 953       953/953
(100 %)
5 diff
(99.5 %id)
BF773526 epid_tumor .a 3862 to 4174 322 to 10     Submitted on the opposite strand 313/322
(97 %)
5 diff
(98.5 %id)
DB514158 testis .a 4044 to 4478 1 to 436     Submitted on the opposite strand 436/436
(100 %)
8 diff
(98.2 %id)
AL578245 placenta .a 4080 to 5097 1014 to 1       1014/1014
(100 %)
9 diff
(99.2 %id)
CN288380 embryonic stem cells, cell lines H1, H7, andH9 .a 4086 to 4612 1 to 528       528/528
(100 %)
6 diff
(98.9 %id)
AA354817   .a 4113 to 4420 1 to 309       309/309
(100 %)
1 diff
(99.7 %id)
AW958435   .a 4121 to 4682 8 to 573       566/575
(98 %)
20 diff
(96.6 %id)
CX762829 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4127 to 4918 1 to 791     Submitted on the opposite strand 791/791
(100 %)
7 diff
(99.2 %id)
CB142940 Liver .a 4143 to 4760 1 to 613       613/613
(100 %)
2 diff
(99.7 %id)
AU149454   .a 4548 to 5125 579 to 1       579/580
(99 %)
8 diff
(98.7 %id)
AU155477 ovary, tumor tissue .a 4891 to 5391 497 to 1   tiling clone,   497/497
(100 %)
12 diff
(97.6 %id)
DC349800 brain .b 1 to 578 1 to 578   tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
DC360376   .b 4 to 547 1 to 544       544/544
(100 %)
2 diff
(99.7 %id)
AK299349   .b 30 to 3245 1 to 3216   tiling clone,   3216/3216
(100 %)
4 diff
(99.9 %id)
DC372627   .b 30 to 586 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DC375609 brain .b 74 to 658 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BU664351 blood .b 84 to 274 9 to 197       189/197
(95 %)
6 diff
(97.0 %id)
DC324308 brain .b 97 to 678 1 to 582       582/594
(97 %)
2 diff
(99.7 %id)
DC334944 hippocampus .b 103 to 652 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC370344   .c 1 to 758 1 to 757   tiling clone,   757/758
(99 %)
3 diff
(99.7 %id)
DC376520 brain .c 3 to 486 1 to 484   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
DA143853 amygdala .c 69 to 356 2 to 289   capped   288/288
(100 %)
0 diff
(100 %id)
DC426365   .c 2680 to 3150 477 to 1   tiling clone,   477/548
(87 %)
14 diff
(97.5 %id)
DA389647 thalamus .d 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BM543977 ovary (pool of 3) .d 401 to 1215 1 to 821   tiling clone,   821/1198
(68 %)
19 diff
(98.5 %id)
AL042935 testis .e 1 to 709 1 to 705 T9S S217L S218L C219P Q220S ... tiling clone,   705/720
(97 %)
7 diff
(99.1 %id)
AK126552   .f 1 to 4792 2 to 4792 exact tiling clone, available from FLJ,   4792/4792
(100 %)
19 diff
(99.7 %id)
DA034151   .f 1 to 504 2 to 509   capped   508/508
(100 %)
6 diff
(98.9 %id)
CN269000 embryonic stem cells, DMSO-treated H9 cellline .f 855 to 1496 1 to 642   tiling clone,   642/642
(100 %)
0 diff
(100 %id)
AA442397   .f 998 to 1579 1 to 579   tiling clone,   579/579
(100 %)
6 diff
(99.0 %id)
BX954025   .f 1595 to 2114 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
DB151468 thymus .f 1650 to 2209 2 to 561   tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
DB346167 thymus .f 4241 to 4792 553 to 1   tiling clone,   553/553
(100 %)
2 diff
(99.7 %id)
DB295848   .f 4256 to 4792 537 to 1       537/537
(100 %)
2 diff
(99.7 %id)
W87501 liver and spleen .f 4386 to 4626 1 to 242     Submitted on the opposite strand 242/242
(100 %)
2 diff
(99.2 %id)
BG997987 head_neck .f 4501 to 4811 1 to 310   tiling clone,   310/310
(100 %)
6 diff
(98.1 %id)
DA096667 cerebellum .g-u 1 to 496 2 to 498   tiling clone, capped   497/497
(100 %)
1 diff
(99.8 %id)
CR989007 T-Lymphocytes .g-u 36 to 548 1 to 518       518/524
(98 %)
6 diff
(98.9 %id)
CB268047 adipose .g-u 102 to 699 1 to 598   tiling clone,   598/598
(100 %)
5 diff
(99.2 %id)
CN288375 embryonic stem cells, cell lines H1, H7, andH9 .g-u 121 to 646 1 to 526   tiling clone,   526/526
(100 %)
1 diff
(99.9 %id)
CN288377 embryonic stem cells, cell lines H1, H7, andH9 .g-u 388 to 544 1 to 157       157/157
(100 %)
2 diff
(98.8 %id)
BI017558 lung_tumor .g-u 531 to 769 1 to 236   tiling clone,   236/244
(96 %)
6 diff
(97.6 %id)
AL600782   .h 1 to 367 1 to 366   tiling clone,   366/366
(100 %)
2 diff
(99.5 %id)
BX488443   .h 226 to 911 1 to 694   tiling clone,   692/694
(99 %)
12 diff
(98.3 %id)
BI053787 placenta_normal .h 670 to 1067 19 to 415   tiling clone,   397/415
(95 %)
6 diff
(98.6 %id)
BP292741 lung .h 799 to 1380 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BI964242.
matches multiple genes
Islets of Langerhans, Pancreas .i-u 1 to 552 1 to 556   tiling clone, also hits gene C7orf46 556/556
(100 %)
3 diff
(99.5 %id)
BI964096 Islets of Langerhans, Pancreas .i-u 1 to 539 1 to 543   tiling clone,   543/543
(100 %)
3 diff
(99.5 %id)
DA568426 whole embryo, mainly head .i-u 1216 to 1863 2 to 649   tiling clone, to resequence, capped   648/650
(99 %)
4 diff
(99.4 %id)
GD158258   .i-u 1225 to 1461 243 to 7     Submitted on the opposite strand 237/244
(97 %)
0 diff
(100 %id)
CA307551 Alveolar Macrophage, lung .i-u 1255 to 2030 777 to 1       777/777
(100 %)
4 diff
(99.5 %id)
H80593 liver and spleen .i-u 1256 to 1542 1 to 292   fully sequenced,   292/292
(100 %)
8 diff
(97.3 %id)
W04454 liver and spleen .i-u 1256 to 1607 1 to 350   fully sequenced,   350/350
(100 %)
9 diff
(97.5 %id)
BX093598 liver and spleen .i-u 1257 to 2012 1 to 756   AAA   756/756
(100 %)
4 diff
(99.5 %id)
CN288376 embryonic stem cells, DMSO-treated H9 cellline .i-u 1267 to 1960 1 to 692       692/698
(99 %)
4 diff
(99.5 %id)
CX753821 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i-u 1295 to 2028 727 to 1       727/822
(88 %)
21 diff
(97.5 %id)
CN288374 embryonic stem cells, DMSO-treated H9 cellline .i-u 1324 to 1548 1 to 225       225/225
(100 %)
0 diff
(100 %id)
BM669643 eye, fetal eyes .i-u 1329 to 1856 8 to 535   AAA Submitted on the opposite strand 528/535
(98 %)
6 diff
(98.9 %id)
AA906552 carcinoid, lung .i-u 1345 to 1497 1 to 149     Submitted on the opposite strand 149/149
(100 %)
9 diff
(94.0 %id)
FN173989 breast carcinoma .i-u 1368 to 1471 105 to 1     Submitted on the opposite strand 105/110
(95 %)
3 diff
(97.3 %id)
BF751552 breast_normal .i-u 1421 to 1831 411 to 1     Submitted on the opposite strand 411/419
(98 %)
10 diff
(97.7 %id)
BI963814 Islets of Langerhans, Pancreas .i-u 1432 to 2017 589 to 1       589/589
(100 %)
3 diff
(99.5 %id)
BI963921.
matches multiple genes
Islets of Langerhans, Pancreas .i-u 1435 to 2017 586 to 1     also hits gene C7orf46 586/586
(100 %)
3 diff
(99.5 %id)
BQ003784 Chondrosarcoma, Left Pelvis .i-u 1445 to 2030 586 to 1       586/586
(100 %)
1 diff
(99.9 %id)
BQ022859 placenta .i-u 1449 to 2030 583 to 1       583/583
(100 %)
2 diff
(99.7 %id)
AI888451 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i-u 1489 to 2018 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
BM698858 eye, fetal eyes .i-u 1489 to 2031 557 to 14   tiling clone, Submitted on the opposite strand 544/557
(97 %)
0 diff
(100 %id)
AA700232 liver and spleen .i-u 1494 to 2012 520 to 1       520/520
(100 %)
4 diff
(99.3 %id)
AI027781   .i-u 1494 to 1967 1 to 476   AAA Submitted on the opposite strand 476/476
(100 %)
4 diff
(99.2 %id)
BI087256 cervix .i-u 1499 to 2045 11 to 560       550/1045
(52 %)
14 diff
(98.7 %id)
TI_149312503   .i-u 1506 to 2271 844 to 88   AAA Possibly primed on the genome, locally A rich (20/23 A in genome downstream of last aligned base) 757/961
(78 %)
14 diff
(98.6 %id)
AI207541 Liver .i-u 1511 to 2032 525 to 4       522/525
(99 %)
0 diff
(100 %id)
H80536 liver and spleen .i-u 1512 to 1980 480 to 1   fully sequenced,   480/480
(100 %)
16 diff
(96.7 %id)
CA444448 lung, Metastatic Chondrosarcoma .i-u 1521 to 2030 512 to 1       512/517
(99 %)
5 diff
(99.1 %id)
BG236420 blood, lymphocyte .i-u 1552 to 2022 471 to 1       471/471
(100 %)
0 diff
(100 %id)
N73555 liver and spleen .i-u 1566 to 2012 450 to 1       450/450
(100 %)
2 diff
(99.6 %id)
BG029530 breast, mammary adenocarcinoma, cell line .i-u 1569 to 2065 1 to 506       506/1275
(39 %)
24 diff
(98.2 %id)
BP389388 pancreatic islet .i-u 1571 to 1965 7 to 402     Submitted on the opposite strand 396/402
(98 %)
6 diff
(98.6 %id)
N76049 liver and spleen .i-u 1577 to 2012 444 to 1   fully sequenced,   444/444
(100 %)
5 diff
(98.9 %id)
AW076028 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .i-u 1582 to 2013 429 to 1       429/429
(100 %)
3 diff
(99.4 %id)
BM978074 lung .i-u 1583 to 2297 705 to 1       705/705
(100 %)
7 diff
(99.1 %id)
BX348608   .i-u 1602 to 2012 39 to 451   AAA   413/451
(91 %)
6 diff
(98.7 %id)
AI827797 pooled .i-u 1603 to 2014 409 to 1       409/409
(100 %)
7 diff
(98.3 %id)
AA565400 germ cell tumor .i-u 1615 to 2013 400 to 1       400/400
(100 %)
4 diff
(99.0 %id)
BQ022639 placenta .i-u 1615 to 2030 416 to 1       416/416
(100 %)
2 diff
(99.6 %id)
AA702631 pineal gland .i-u 1622 to 2018 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
AA679065 pineal gland .i-u 1625 to 2015 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AI188206   .i-u 1626 to 2024 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AA552545 colon, tumor .i-u 1629 to 2011 382 to 1       382/382
(100 %)
1 diff
(99.8 %id)
AA702559 pineal gland .i-u 1631 to 2018 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
AA705360 liver and spleen .i-u 1631 to 2012 382 to 1       382/383
(99 %)
2 diff
(99.5 %id)
AA995701 2 pooled tumors (clear cell type), Kidney .i-u 1647 to 2017 371 to 1       371/371
(100 %)
2 diff
(99.5 %id)
BP389503 pancreatic islet .i-u 1652 to 2016 1 to 365     Submitted on the opposite strand 365/365
(100 %)
0 diff
(100 %id)
CX163625 human embryonic stem cells differentiated toan early endodermal cell type .i-u 1678 to 2356 19 to 700       682/700
(97 %)
6 diff
(99.2 %id)
AA969997 pooled .i-u 1688 to 2016 332 to 1       332/380
(87 %)
10 diff
(97.4 %id)
F36561 pectoral muscle (after mastectomy) .i-u 1693 to 2005 1 to 312       312/312
(100 %)
8 diff
(97.5 %id)
BG032370 breast, mammary adenocarcinoma, cell line .i-u 1697 to 2050 1 to 352       352/635
(55 %)
6 diff
(99.1 %id)
F30872 pectoral muscle (after mastectomy) .i-u 1706 to 1884 1 to 178       178/178
(100 %)
5 diff
(97.2 %id)
AI911157 pooled .i-u 1708 to 2007 310 to 11       300/310
(96 %)
0 diff
(100 %id)
DW446052 Liver .i-u 1712 to 1919 10 to 219       210/219
(95 %)
12 diff
(94.6 %id)
AW513927 colon, juvenile granulosa tumor .i-u 1717 to 2018 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AA872169 pooled germ cell tumors .i-u 1724 to 2014 291 to 1       291/291
(100 %)
0 diff
(100 %id)
BG993833 head_neck .i-u 1762 to 2020 1 to 264       264/275
(96 %)
23 diff
(91.7 %id)
AA569003 colon, colon tumor RER+ .i-u 1774 to 2013 240 to 1       240/240
(100 %)
1 diff
(99.6 %id)
AW265438 moderate to poorly differentiated invasivecarcinoma, tongue .i-u 1778 to 2115 8 to 348     Submitted on the opposite strand 341/348
(97 %)
6 diff
(98.3 %id)
AW265440 moderate to poorly differentiated invasivecarcinoma, tongue .i-u 1778 to 2244 8 to 477     Submitted on the opposite strand 470/477
(98 %)
6 diff
(98.8 %id)
DW442740 Liver .i-u 1782 to 2008 8 to 233       226/233
(96 %)
6 diff
(97.5 %id)
AI245120 Kidney .i-u 1783 to 2053 48 to 321     Submitted on the opposite strand 274/321
(85 %)
6 diff
(98.2 %id)
AA135535 uterus .i-u 1798 to 2004 1 to 207       207/207
(100 %)
5 diff
(97.6 %id)
AA148448 uterus .i-u 1799 to 2254 1 to 460       460/463
(99 %)
5 diff
(99.0 %id)
AI806618 pooled .i-u 1828 to 2278 453 to 1       453/453
(100 %)
6 diff
(98.7 %id)
FN130945 breast carcinoma .i-u 1835 to 1934 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
AA625055 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 1856 to 1953 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
BM932135 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i-u 1865 to 2278 1 to 417   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 417/417
(100 %)
1 diff
(99.8 %id)
AA746410 germinal center B cell .i-u 1898 to 2156 261 to 1       261/261
(100 %)
1 diff
(99.7 %id)
BE939339 uterus .i-u 1899 to 2076 1 to 178       178/179
(99 %)
13 diff
(92.8 %id)
AW614958 carcinoid, lung .i-u 1903 to 2277 381 to 1       381/389
(97 %)
9 diff
(97.7 %id)
AA653601   .i-u 1913 to 2268 389 to 34   AAA Possibly primed on the genome, locally A rich (22/26 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
AA825834 germinal center B cell .i-u 1917 to 2284 373 to 4       370/373
(99 %)
0 diff
(100 %id)
AA948578 pooled .i-u 1918 to 2281 366 to 1       366/366
(100 %)
1 diff
(99.8 %id)
BE674606 carcinoid, lung .i-u 1940 to 2281 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
BU620006 Cell Line, Chondrosarcoma .i-u 1956 to 2367 24 to 438   AAA Submitted on the opposite strand 415/438
(94 %)
6 diff
(98.7 %id)
BF115769 carcinoid, lung .i-u 1961 to 2282 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
AA954611 2 pooled tumors (clear cell type), Kidney .i-u 1974 to 2156 187 to 1       187/187
(100 %)
2 diff
(99.0 %id)
AI752994 bone marrow stroma .i-u 2014 to 2278 283 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 265/265
(100 %)
0 diff
(100 %id)
BQ058271 lymph, lymphoma, cell line .i-u 2017 to 2849 27 to 880 R3E G4R V5G R6X R7X ... tiling clone,   854/1039
(82 %)
42 diff
(96.0 %id)
BM150472 leukopheresis .i-u 2030 to 2268 257 to 19   AAA Possibly primed on the genome, locally A rich (22/26 A in genome downstream of last aligned base) 239/274
(87 %)
4 diff
(98.6 %id)
AA135538.
matches multiple genes
uterus .i-u 2031 to 2273 243 to 1     also hits gene TBC1D14 243/246
(98 %)
0 diff
(100 %id)
AI680664 carcinoid, lung .i-u 2042 to 2270 229 to 1       229/229
(100 %)
0 diff
(100 %id)
AI970356 pooled germ cell tumors .i-u 2051 to 2552 502 to 1       502/502
(100 %)
3 diff
(99.5 %id)
BE876146 large cell carcinoma, undifferentiated, lung .i-u 2058 to 2702 1 to 645 I89M     645/646
(99 %)
7 diff
(99.0 %id)
BI046408 prostate_normal .i-u 2079 to 2533 1 to 458       458/458
(100 %)
8 diff
(98.3 %id)
CN288382 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i-u 2111 to 2784 1 to 674 exact     674/674
(100 %)
0 diff
(100 %id)
BM798129 Ascites, stomach .i-u 2155 to 2316 1 to 162       162/162
(100 %)
0 diff
(100 %id)
BF222387 Prostate .i-u 2193 to 2574 382 to 1       382/382
(100 %)
0 diff
(100 %id)
F25125 pectoral muscle (after mastectomy) .i-u 2205 to 2324 1 to 120       120/120
(100 %)
1 diff
(99.2 %id)
AA194203 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2215 to 2351 1 to 137       137/137
(100 %)
0 diff
(100 %id)
AW594717 pooled germ cell tumors .i-u 2230 to 2558 335 to 1       335/335
(100 %)
7 diff
(98.0 %id)
BF510402   .i-u 2242 to 2572 349 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 332/342
(97 %)
3 diff
(99.2 %id)
AI637462 pooled germ cell tumors .i-u 2248 to 2576 329 to 1       329/329
(100 %)
4 diff
(98.8 %id)
AA910566 pooled germ cell tumors .i-u 2269 to 2575 307 to 1       307/307
(100 %)
4 diff
(98.7 %id)
BE504876 pooled germ cell tumors .i-u 2269 to 2572 307 to 4       304/307
(99 %)
0 diff
(100 %id)
AI365114 pooled germ cell tumors .i-u 2275 to 2572 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AI653290 pooled germ cell tumors .i-u 2275 to 2572 298 to 1       298/298
(100 %)
0 diff
(100 %id)
BE046005 pooled germ cell tumors .i-u 2275 to 2572 298 to 1       298/298
(100 %)
0 diff
(100 %id)
TI_149274377   .i-u 2279 to 2962 769 to 86 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 684/990
(69 %)
3 diff
(99.7 %id)
AA150661 uterus .i-u 2286 to 2569 1 to 284   fully sequenced,   284/284
(100 %)
1 diff
(99.7 %id)
AJ707809 heart .i-u 2309 to 2842 1 to 533 exact     533/533
(100 %)
2 diff
(99.7 %id)
CA435807 lung, Metastatic Chondrosarcoma .i-u 2350 to 2981 649 to 18 V5L tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 632/648
(97 %)
1 diff
(99.9 %id)
BM968533 lung, Primary Lung Epithelial Cells .i-u 2355 to 2962 626 to 19 exact AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 608/608
(100 %)
0 diff
(100 %id)
AI082556 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2369 to 2826 456 to 1       456/472
(96 %)
5 diff
(99.0 %id)
EC526774 Prostate .i-u 2379 to 2487 1 to 107       107/107
(100 %)
9 diff
(91.6 %id)
DB354938 whole embryo, mainly head .i-u 2392 to 2964 572 to 1   to resequence,   572/574
(99 %)
25 diff
(95.7 %id)
AA988945 carcinoid, lung .i-u 2430 to 2961 533 to 1       533/533
(100 %)
5 diff
(99.1 %id)
AI761803 colon, colon tumor, RER+ .i-u 2448 to 2959 512 to 1       512/512
(100 %)
1 diff
(99.9 %id)
AI125428   .i-u 2449 to 2963 517 to 3       515/517
(99 %)
0 diff
(100 %id)
AI702951 carcinoid, lung .i-u 2449 to 2961 513 to 1       513/513
(100 %)
2 diff
(99.7 %id)
EC557775 Prostate .i-u 2463 to 2557 104 to 13       92/104
(88 %)
0 diff
(100 %id)
BM701571 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i-u 2466 to 2962 1 to 497   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 497/497
(100 %)
0 diff
(100 %id)
BF433266 carcinoid, lung .i-u 2468 to 2963 498 to 3       496/498
(99 %)
0 diff
(100 %id)
AI572520 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2473 to 2964 507 to 1       507/510
(99 %)
63 diff
(87.7 %id)
BE218837 carcinoid, lung .i-u 2485 to 2961 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AI266096 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2487 to 2964 479 to 1       479/480
(99 %)
1 diff
(99.8 %id)
BE503318 pooled germ cell tumors .i-u 2489 to 2963 479 to 5       475/479
(99 %)
0 diff
(100 %id)
AI337033 pooled germ cell tumors .i-u 2490 to 2964 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AI653708 pooled germ cell tumors .i-u 2490 to 2961 478 to 7       472/478
(98 %)
0 diff
(100 %id)
BE463805 pooled germ cell tumors .i-u 2490 to 2978 491 to 3       489/491
(99 %)
0 diff
(100 %id)
BE677920 pooled .i-u 2490 to 2944 468 to 14   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 455/455
(100 %)
1 diff
(99.8 %id)
AI139676 heart .i-u 2492 to 2963 473 to 2       472/473
(99 %)
0 diff
(100 %id)
AI652800 pooled germ cell tumors .i-u 2492 to 2961 473 to 3       471/473
(99 %)
0 diff
(100 %id)
BF431048 pooled .i-u 2492 to 2962 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AI916991 pooled germ cell tumors .i-u 2495 to 2963 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
AI985462 Kidney .i-u 2495 to 2826 332 to 1       332/337
(98 %)
0 diff
(100 %id)
AI803280 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2497 to 2963 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
BF447792 carcinoid, lung .i-u 2497 to 2963 472 to 6       467/472
(98 %)
0 diff
(100 %id)
AW197278 pooled germ cell tumors .i-u 2499 to 2965 468 to 1       468/468
(100 %)
4 diff
(99.2 %id)
AA987384 Kidney, kidney tumor .i-u 2501 to 2810 310 to 1       310/310
(100 %)
0 diff
(100 %id)
AI147595 uterus .i-u 2501 to 2962 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AA931169 pooled germ cell tumors .i-u 2517 to 2981 464 to 1       464/464
(100 %)
5 diff
(99.0 %id)
BF222326 Prostate .i-u 2526 to 2962 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI498047 anaplastic oligodendroglioma, brain .i-u 2538 to 2963 430 to 5       426/430
(99 %)
0 diff
(100 %id)
AA142951 uterus .i-u 2539 to 2964 420 to 1   fully sequenced,   420/420
(100 %)
2 diff
(99.6 %id)
AA564451 colon .i-u 2550 to 2962 421 to 7       415/421
(98 %)
0 diff
(100 %id)
AW016429   .i-u 2562 to 2962 418 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
BE327019 Kidney .i-u 2586 to 2822 247 to 11   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 237/237
(100 %)
1 diff
(99.6 %id)
AA194045 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2595 to 2962 368 to 1       368/368
(100 %)
3 diff
(99.2 %id)
BM272250 Pancreas, Purified pancreatic islet .i-u 2615 to 2965 353 to 3       351/353
(99 %)
0 diff
(100 %id)
BM272468 Pancreas, Purified pancreatic islet .i-u 2624 to 2964 1 to 341   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 341/341
(100 %)
0 diff
(100 %id)
AI825082 pooled germ cell tumors .i-u 2627 to 2963 343 to 5       339/343
(98 %)
0 diff
(100 %id)
AI950293 pooled germ cell tumors .i-u 2641 to 2964 320 to 1       320/324
(98 %)
9 diff
(97.3 %id)
AI637645 pooled germ cell tumors .i-u 2645 to 2962 328 to 11   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 318/318
(100 %)
0 diff
(100 %id)
AI652552 pooled germ cell tumors .i-u 2645 to 2952 318 to 11       308/318
(96 %)
0 diff
(100 %id)
AI962838 pooled germ cell tumors .i-u 2645 to 2963 327 to 9       319/327
(97 %)
0 diff
(100 %id)
BE502313 pooled germ cell tumors .i-u 2645 to 2962 322 to 1       322/322
(100 %)
4 diff
(98.8 %id)
AA810151 germinal center B cell .i-u 2646 to 2962 338 to 21   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 318/318
(100 %)
3 diff
(99.1 %id)
AI207145 pooled germ cell tumors .i-u 2650 to 2962 313 to 1       313/313
(100 %)
4 diff
(98.8 %id)
AW612315 Kidney .i-u 2652 to 2963 314 to 2       313/314
(99 %)
0 diff
(100 %id)
AA479986 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2659 to 2962 306 to 1       306/306
(100 %)
3 diff
(99.1 %id)
D20191   .i-u 2668 to 2963 1 to 296     Submitted on the opposite strand 296/298
(99 %)
1 diff
(99.7 %id)
AI382367   .i-u 2674 to 2944 283 to 13   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 271/271
(100 %)
0 diff
(100 %id)
AA585321   .i-u 2696 to 2963 263 to 5       259/267
(97 %)
0 diff
(100 %id)
CD640165 pooled .i-u 2727 to 2962 1 to 236   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 236/236
(100 %)
3 diff
(98.8 %id)
BE550423 pooled germ cell tumors .i-u 2731 to 2963 235 to 3       233/240
(97 %)
0 diff
(100 %id)
DC369349   .j 1 to 565 1 to 565   tiling clone,   565/565
(100 %)
0 diff
(100 %id)
DC375355 brain .j 30 to 603 1 to 574 P103L tiling clone,   574/574
(100 %)
1 diff
(99.9 %id)
DA444920 tongue, tumor tissue .k 1 to 570 9 to 578   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
DC401484 testis .k 259 to 714 100 to 556   tiling clone,   457/556
(82 %)
7 diff
(98.8 %id)
BP282419 bone marrow .l 1 to 581 1 to 582   tiling clone,   582/582
(100 %)
21 diff
(96.4 %id)
DC304138 cerebellum .l 46 to 631 1 to 586 exact tiling clone,   586/586
(100 %)
1 diff
(99.9 %id)
DC414251 trachea .l 46 to 605 1 to 560   tiling clone,   560/560
(100 %)
2 diff
(99.7 %id)
BQ436729 embryonal carcinoma, cell line, testis .m 1 to 721 15 to 738   tiling clone,   724/916
(79 %)
14 diff
(98.5 %id)
BI055007 placenta_normal .m 281 to 491 211 to 1   tiling clone,   211/211
(100 %)
8 diff
(96.3 %id)
AW316733 brain, three pooled meningiomas .m 949 to 1266 344 to 27   tiling clone, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 318/318
(100 %)
0 diff
(100 %id)
BE242572 leukopheresis .n 1 to 520 520 to 1 exact tiling clone,   520/520
(100 %)
0 diff
(100 %id)
BQ336153 marrow .o-u 1 to 443 445 to 5   tiling clone,   441/445
(99 %)
0 diff
(100 %id)
DB234246 trachea .o-u 109 to 688 2 to 581 exact tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
BM148021 leukopheresis .p 1 to 484 1 to 484   tiling clone,   484/484
(100 %)
1 diff
(99.8 %id)
BM148092 leukopheresis .p 1 to 503 1 to 503 exact tiling clone,   503/503
(100 %)
2 diff
(99.7 %id)
DA108930 cerebellum .q-u 1 to 589 2 to 591 exact tiling clone, capped   590/590
(100 %)
1 diff
(99.9 %id)
BF328559 breast_normal .r-u 1 to 485 29 to 513 Q27* tiling clone,   485/513
(94 %)
6 diff
(98.9 %id)
AW136064   .s-u 1 to 386 386 to 1 exact tiling clone,   386/386
(100 %)
2 diff
(99.5 %id)
BX353507 Neuroblastoma Cot 25-normalized Gene JARID2, variant not shown         This clone was ignored    
GD153444   Gene JARID2, variant not shown       AAA      
AK302624 testis Gene JARID2, variant not shown         Suspected internal deletion, this clone was ignored    
BX092583 pooled germ cell tumors Gene JARID2, variant not shown       AAA      
DB298903 cerebellum Gene JARID2, variant not shown              
DA098283 cerebellum Gene JARID2, variant not shown       capped      
AI824804 pooled germ cell tumors Gene JARID2, variant not shown              
AW237042 pooled germ cell tumors Gene JARID2, variant not shown         Suspected internal deletion, this clone was ignored    
AW445218   Gene JARID2, variant not shown       AAA      
BF508249   Gene JARID2, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
BE552060 pooled germ cell tumors Gene JARID2, variant not shown              
BE671711 pooled germ cell tumors Gene JARID2, variant not shown              
CV802653 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass Gene JARID2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i-u, .j, .k, .l, .m, .n, .o-u, .p, .q-u, .r-u, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI